PSMA-11 PET/MRI for Liver Cirrhosis
Treatments studied
Part of Cancer, Digestive system clinical trials.
This study uses a special PET/MRI scan with a tracer called PSMA-11 to look at how liver cirrhosis affects the liver. It may help doctors better understand and monitor the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with liver cirrhosis (based on imaging, tests, or a biopsy).
- You cannot be pregnant or breastfeeding.
- You must not have any condition that makes a PET or MRI unsafe (like metal implants, severe claustrophobia, or allergies).
- You must not be allergic to gadolinium, the contrast dye used in MRI.
- Your research radiation in the past year must be low enough that the total for this study stays under 50 mSv.
- You must weigh less than 300 lbs and have a BMI below 33 to fit in the scanner.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET/MRI scanner to take detailed pictures of your liver and bile ducts. It may help doctors better understand and manage PSC without any treatment or medication.
This study tests a new type of PET/CT scan (called PSMA) that may help doctors see liver cancer (HCC) better. The scan takes detailed images to track how the cancer behaves, which could help choose the best treatment.
This study tests whether a special scan (PSMA PET/MRI) combined with a standard MRI can better detect prostate cancer. It is for men who have not had a biopsy yet and are suspected of having prostate cancer.
This trial tests whether a new PET imaging agent (GPC3-targeted) can find liver cancer as well as or better than enhanced MRI. It may help diagnose hepatocellular carcinoma (the most common type of liver cancer) more accurately.
This study tests whether a combined PET/MRI scan can better find and see liver tumors or cancer that has spread to the liver. If you are eligible, you will get this special imaging test, which may help doctors diagnose and plan your treatment more accurately.
This study compares two advanced imaging tests — PET/CT and enhanced MRI — to see which one finds liver cancers or spread to the liver more accurately. If you join, you'll get one or both of these scans, which may help your doctor spot issues earlier and plan your care better.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.